Woodline Partners LP Olink Holding Ab (Publ) Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$21.87 - $25.59 $32.2 Million - $37.7 Million	-1,473,856 Reduced 88.14%	198,413 $5.06 Million
Q1 2024 May 15, 2024	SELL	$21.81 - $25.14 $10.1 Million - $11.7 Million	-463,626 Reduced 21.71%	1,672,269 $39.3 Million
Q4 2023 Feb 14, 2024	BUY	$14.29 - $25.95 $14.9 Million - $27.1 Million	1,045,323 Added 95.85%	2,135,895 $53.7 Million
Q3 2023 Nov 14, 2023	SELL	$14.45 - $20.34 $275,055 - $387,171	-19,035 Reduced 1.72%	1,090,572 $16.1 Million
Q2 2023 Aug 14, 2023	BUY	$17.13 - $23.74 $2.76 Million - $3.82 Million	160,960 Added 16.97%	1,109,607 $20.8 Million
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $2.34 Million - $2.92 Million	121,038 Added 14.63%	948,647 $21.4 Million
Q4 2022 Feb 14, 2023	SELL	$12.64 - $25.52 $4.3 Million - $8.69 Million	-340,353 Reduced 29.14%	827,609 $21 Million
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $1.33 Million - $2.01 Million	109,282 Added 10.32%	1,167,962 $14.2 Million
Q2 2022 Aug 15, 2022	BUY	$8.95 - $19.24 $849,211 - $1.83 Million	94,884 Added 9.84%	1,058,680 $16.1 Million
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $1.91 Million - $3.25 Million	168,273 Added 21.15%	963,796 $17 Million
Q4 2021 Feb 14, 2022	BUY	$18.0 - $34.82 $1,728 - $3,342	96 Added 0.01%	795,523 $14.5 Million
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $2.45 Million - $3.96 Million	104,519 Added 15.13%	795,427 $19.3 Million
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $420,643 - $622,994	15,784 Added 2.34%	690,908 $23.8 Million
Q1 2021 May 17, 2021	BUY	$31.9 - $36.0 $21.5 Million - $24.3 Million	675,124 New	675,124 $24.3 Million

Others Institutions Holding OLK

# of Institutions

Shares Held

799K

Call Options Held

Put Options Held

View Full List

About Olink Holding AB (publ)

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

More about OLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account